Siegfried’s 113th Annual Shareholders’ Meeting took place at the Zofingen City Hall and was attended by around 220 shareholders and proxies representing about 50% of the shares. The Shareholders approved the following:
Peter Gehler, Chief Communications Officer
Tel. +41 62 746 11 48
Mobile +41 79 416 41 16
Siegfried Holding AG
Untere Bruehlstrasse 4
Tel. +41 62 746 11 11
The Siegfried Group is active worldwide in the field of Life Sciences with production facilities located in Switzerland, the USA, Malta, China, Germany and France. At the end of 2015, Siegfried reported annual sales of CHF 481 million and employs at the time being approximately 2200 employees at nine locations on three continents. Siegfried Holding AG is listed on the Swiss Exchange (SIX: SFZN).
Siegfried is active in both the primary and secondary production of drugs. The company develops and manufactures active pharmaceutical ingredients for the research-based pharmaceutical industry as well as the corresponding intermediates and controlled substances, and provides development and production services for finished dosage forms including sterile filling.